Skip to content
← Survival collections

POPULATION SURVIVAL

HR-/HER2- Breast Cancer (Female only)

Published source values

Female · All Ages · All Stages · All Races / Ethnicities

Source
SEER
Table
Recent Trends
Data submission
November 2025 submission
Application release
Updated
June 22, 2026
Retrieved
Diagnosis years
2010 to 2022
5-year Relative Survival by diagnosis year for HR-/HER2- Breast Cancer (Female only). Source table: SEER Recent Trends.
Diagnosis yearRelative survival (%)Lower CIUpper CIStandard errorModeled (%)Source count
201077.70918776.58791878.7844520.56026077.6960287359
201176.91658575.82739677.9640890.54501377.7806617944
201278.23174877.13680679.2815330.54704277.8650217718
201378.14571377.04979579.1966050.54757477.9491077668
201477.34833576.25542678.3983200.54658878.0329217868
201577.93478776.86051678.9662450.53710378.1164638067
201678.34293077.26664379.3752930.53784178.1997338058
201778.45369677.40867179.4570120.52246278.2827338583
201879.38351578.34257580.3808890.51989178.3654618612
2019Not publishedNot publishedNot publishedNot published78.447920Not published
2020Not publishedNot publishedNot publishedNot published78.530110Not published
2021Not publishedNot publishedNot publishedNot published78.612030Not published
2022Not publishedNot publishedNot publishedNot published78.693682Not published

Open the SEER source

Filters stay in your browser. Some combinations have no estimate.

SEER · SOURCE POPULATIONS

Recent survival trends

Compare diagnosis years, not years since diagnosis. These estimates describe different diagnosis eras—not one person’s changing outlook.

Loading the exact source populations…

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Relative survival compares cancer populations with the general population. It is not the percentage of people alive, a treatment effect, or a personal forecast. Diagnosis-period dates were not labeled in the recovered package; see the source notes below.